[68ga]ga-htk03149
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 30, 2021 (NCT04831307)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05570994 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2023 | British Columbia Cancer Agency |
| NCT04831307 | N/A | Aug 30, 2021 | British Columbia Cancer Agency |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| British Columbia Cancer Agency | Academic/Hospital | 2 | 2 | 2 | 2021 |
1 organizations
Page 1 / 1